Publication:
Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: An analysis of 53 cases

Simple item page
dc.contributor.authorOnal, Ugur
dc.contributor.authorAkyol, Deniz
dc.contributor.authorKaya, Arda
dc.contributor.authorBaskol, Dilsah
dc.contributor.authorKenanoglu, Buse
dc.contributor.authorSanlidag, Gamze
dc.contributor.authorOnal, Ayse Uyan
dc.contributor.authorAvsar, Cansu Bulut
dc.contributor.authorMert, Merve
dc.contributor.authorMemetali, Seichan
dc.contributor.authorErdem, Hueseyin Aytac
dc.contributor.authorBozkurt, Devrim
dc.contributor.authorSimsir, Adnan
dc.contributor.authorBozbiyik, Osman
dc.contributor.authorKahraman, Umit
dc.contributor.authorOzgiray, Erkin
dc.contributor.authorKorkmaz, Pervin
dc.contributor.authorCilli, Feriha
dc.contributor.authorPullukcu, Husnu
dc.contributor.authorYamazhan, Tansu
dc.contributor.authorTasbakan, Meltem Isikgoz
dc.contributor.authorArda, Bilgin
dc.contributor.authorUlusoy, Sercan
dc.contributor.authorSipahi, Oguz Resat
dc.contributor.buuauthorÖNAL, UĞUR
dc.contributor.orcid0000-0001-6194-3254
dc.contributor.researcheridJCO-3678-2023
dc.date.accessioned2024-11-07T07:58:26Z
dc.date.available2024-11-07T07:58:26Z
dc.date.issued2023-10-01
dc.description.abstractHerein, we aimed to describe the outcomes of patients with blood stream infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) who received ertapenem plus meropenem combination treatment (EMCT). A total of 53 patients with culture proven CR-Kp bacteremia treated with ertapenem + meropenem were included. The patients with secondary bacteremia due to urinary tract infection exhibited a significantly lower 1-month mortality (OMM), particularly in those with microbiological eradication and those with end-of-treatment success. Salvage EMCT resulted in 49% 1-month survival.
dc.identifier.doi10.1007/s10096-023-04660-3
dc.identifier.endpage1273
dc.identifier.issn0934-9723
dc.identifier.issue10
dc.identifier.startpage1269
dc.identifier.urihttps://doi.org/10.1007/s10096-023-04660-3
dc.identifier.urihttps://hdl.handle.net/11452/47542
dc.identifier.volume42
dc.identifier.wos001063955100001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherSpringer
dc.relation.journalEuropean Journal Of Clinical Microbiology & Infectious Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTherapy
dc.subjectInfections
dc.subjectDouble carbapenem therapy
dc.subjectCarbapenem-resistant klebsiella pneumonia
dc.subjectBacteremia
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectInfectious diseases
dc.subjectMicrobiology
dc.subjectInfectious diseases
dc.subjectMicrobiology
dc.titleErtapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: An analysis of 53 cases
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication73351d49-e518-4e6a-8f69-c922f8f24611
relation.isAuthorOfPublication.latestForDiscovery73351d49-e518-4e6a-8f69-c922f8f24611

Files

Collections

Yeni Yayınlar